Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy.

Kronbichler A, Oh J, Meijers B, Mayer G, Shin JI.

Biomed Res Int. 2017;2017:1936372. doi: 10.1155/2017/1936372. Epub 2017 Aug 17. Review.

2.

Genetic determinants of the development and course of membranous nephropathy.

Kamyshova ES, Bobkova IN, Gorelova IA, Каkhsurueva PA, Filatova EE.

Ter Arkh. 2018 Jun 20;90(6):105-111. doi: 10.26442/terarkh2018906105-111. Review.

PMID:
30701913
3.

Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.

Wang J, Cui Z, Lu J, Probst C, Zhang YM, Wang X, Qu Z, Wang F, Meng LQ, Cheng XY, Liu G, Debiec H, Ronco P, Zhao MH.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1642-1651. doi: 10.2215/CJN.01460217. Epub 2017 Aug 11.

4.

Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents.

Dettmar AK, Wiech T, Kemper MJ, Soave A, Rink M, Oh J, Stahl RAK, Hoxha E; Pediatric MN Study Group.

Pediatr Nephrol. 2018 Mar;33(3):463-472. doi: 10.1007/s00467-017-3817-y. Epub 2017 Oct 15.

PMID:
29034405
5.

Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.

Tomas NM, Hoxha E, Reinicke AT, Fester L, Helmchen U, Gerth J, Bachmann F, Budde K, Koch-Nolte F, Zahner G, Rune G, Lambeau G, Meyer-Schwesinger C, Stahl RA.

J Clin Invest. 2016 Jul 1;126(7):2519-32. doi: 10.1172/JCI85265. Epub 2016 May 23.

6.

Primary Membranous Nephropathy.

Couser WG.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):983-997. doi: 10.2215/CJN.11761116. Epub 2017 May 26. Review. Erratum in: Clin J Am Soc Nephrol. 2017 Sep 7;12 (9):1528.

7.

[Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].

Pozdzik AA, Debiec H, I Brochériou, Husson C, Rorive S, Broeders N, Le Moine A, Ronco P, Nortier J.

Rev Med Brux. 2015 May-Jun;36(3):166-71. Review. French.

PMID:
26372979
8.

Membranous Nephropathy: A Journey From Bench to Bedside.

Francis JM, Beck LH Jr, Salant DJ.

Am J Kidney Dis. 2016 Jul;68(1):138-47. doi: 10.1053/j.ajkd.2016.01.030. Epub 2016 Apr 13. Review.

10.

A Proposal for a Serology-Based Approach to Membranous Nephropathy.

De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC.

J Am Soc Nephrol. 2017 Feb;28(2):421-430. doi: 10.1681/ASN.2016070776. Epub 2016 Oct 24. Review.

11.

Membranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients.

Ronco P, Debiec H.

Mol Immunol. 2015 Nov;68(1):57-62. doi: 10.1016/j.molimm.2015.07.003. Review.

12.

Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.

Hayashi N, Akiyama S, Okuyama H, Matsui Y, Adachi H, Yamaya H, Maruyama S, Imai E, Matsuo S, Yokoyama H.

Clin Exp Nephrol. 2015 Oct;19(5):797-803. doi: 10.1007/s10157-014-1064-0. Epub 2014 Dec 10.

PMID:
25492250
13.

Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy.

Hoxha E, Harendza S, Pinnschmidt HO, Tomas NM, Helmchen U, Panzer U, Stahl RA.

Nephrol Dial Transplant. 2015 Nov;30(11):1862-9. doi: 10.1093/ndt/gfv228. Epub 2015 Jul 3.

PMID:
26142398
14.

[Membranous nephropathy: Pathophysiology and natural history].

Seitz-Polski B, Lambeau G, Esnault V.

Nephrol Ther. 2017 Apr;13 Suppl 1:S75-S81. doi: 10.1016/j.nephro.2017.01.012. Review. French.

PMID:
28577747
15.

PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians.

Ramachandran R, Kumar V, Kumar A, Yadav AK, Nada R, Kumar H, Kumar V, Rathi M, Kohli HS, Gupta KL, Sakhuja V, Jha V.

Nephrol Dial Transplant. 2016 Sep;31(9):1486-93. doi: 10.1093/ndt/gfv399. Epub 2015 Dec 15.

PMID:
26673907
16.

Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy.

Iwakura T, Ohashi N, Kato A, Baba S, Yasuda H.

PLoS One. 2015 Sep 22;10(9):e0138841. doi: 10.1371/journal.pone.0138841. eCollection 2015.

17.

Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.

Pourcine F, Dahan K, Mihout F, Cachanado M, Brocheriou I, Debiec H, Ronco P.

PLoS One. 2017 Mar 3;12(3):e0173201. doi: 10.1371/journal.pone.0173201. eCollection 2017.

18.

PLA2R and THSD7A: Disparate Paths to the Same Disease?

Beck LH Jr.

J Am Soc Nephrol. 2017 Sep;28(9):2579-2589. doi: 10.1681/ASN.2017020178. Epub 2017 Jul 3. Review.

19.

Membranous nephropathy-one morphologic pattern with different diseases.

Hoxha E, von Haxthausen F, Wiech T, Stahl RAK.

Pflugers Arch. 2017 Aug;469(7-8):989-996. doi: 10.1007/s00424-017-2000-4. Epub 2017 May 29. Review.

PMID:
28555350
20.

THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1.

Lin F, Zhang D, Chang J, Tang X, Guan W, Jiang G, Zhu C, Bian F.

Eur J Med Genet. 2018 Feb;61(2):84-88. doi: 10.1016/j.ejmg.2017.10.014. Epub 2017 Oct 25.

PMID:
29079545

Supplemental Content

Support Center